Dengue Vaccine Poised for Roll-Out But Safety Concerns Linger
November 9, 2022
(Nature) – A vaccine to prevent infection from dengue — a mosquito-borne disease that kills 20,000 people a year — is poised to roll out in Indonesia next year. But the jab is stirring debate: some researchers say that important safety concerns have been overlooked. The vaccine, called Qdenga and developed by the pharmaceutical company Takeda, headquartered in Tokyo, is particularly significant because it is the first for people who have not been exposed to dengue. The virus infects up to 400 million people a year. The Indonesian drug regulator approved use of the vaccine without testing for previous exposure in August. Europe’s drug regulator is also considering approving the vaccine without testing. (Read More)